IHS Chemical Week

Chemical Week Magazine :: Other

Low-Cost Insulin from Crops in Three Years?

1:44 PM MDT | April 18, 2007 | Chemical Week Editorial Staff

Sembiosys Genetics (Calgary, AB) says it is on track to launch insulin produced from genetically modified (GM) plants within three years. The company says it has made significant scientific breakthroughs in recent months and identified a “short cut” through existing drug regulations. Sembiosys has engineered a GM safflower that produces insulin, identical to synthetically produced insulin but at a significantly lower cost, the company says (CW, Jan. 24, p. 35). One large farm producing the newly developed insulin could satisfy global insulin demand...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa